Mirum Pharmaceuticals, Inc. (MIRM) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated June 15, 2026, details the results of Mirum Pharmaceuticals, Inc.'s 2026 Annual Meeting of Stockholders. The Company is incorporated in Delaware and its common stock trades on the Nasdaq Global Market under the symbol MIRM. As of the record date of April 20, 2026, there were 60,977,841 shares of common stock outstanding and entitled to vote.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes rather than financial performance.
Material Changes and Voting Results
Stockholders voted on three proposals at the Annual Meeting:
- Proposal 1: Election of Directors - Stockholders elected three Class I directors to serve until the 2029 annual meeting.
- Lon Cardon, Ph.D., FMedSci: 39,587,327 votes For; 6,827,214 votes Withheld.
- William Fairey: 40,266,848 votes For; 6,147,693 votes Withheld.
- Timothy Walbert: 32,329,718 votes For; 14,084,823 votes Withheld.
- Proposal 2: Ratification of Independent Auditor - Stockholders ratified the selection of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
- Results: 49,993,514 votes For; 5,674 votes Against; 30,192 Abstentions.
- Proposal 3: Advisory Vote on Executive Compensation - Stockholders approved the compensation of named executive officers on an advisory basis.
- Results: 44,534,575 votes For; 1,866,719 votes Against; 13,247 Abstentions.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to reporting the outcomes of the shareholder vote.
Key Facts for Investor Verification
- Verify the tenure of the newly elected directors (Class I) which extends to the 2029 annual meeting.
- Note the significant number of votes withheld for director Timothy Walbert (14,084,823) compared to his colleagues.
- Confirm the appointment of Ernst & Young LLP as the auditor for the fiscal year ending December 31, 2026.
- Review the Proxy Statement referenced in the filing for detailed executive compensation data.